APA (7th ed.) Citation

SAR, S., IS, A., AS, A., H, A., RS, A., N, A., . . . AM, A. (2024). The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism. European journal of clinical pharmacology, 80(6), 869. https://doi.org/10.1007/s00228-024-03658-w

Chicago Style (17th ed.) Citation

SAR, Shilbayeh, Adeen IS, Alhazmi AS, Aljurayb H, Altokhais RS, Alhowaish N, Aldilaijan KE, Kamal M, and Alnakhli AM. "The Polymorphisms of Candidate Pharmacokinetic and Pharmacodynamic Genes and Their Pharmacogenetic Impacts on the Effectiveness of Risperidone Maintenance Therapy Among Saudi Children with Autism." European Journal of Clinical Pharmacology 80, no. 6 (2024): 869. https://doi.org/10.1007/s00228-024-03658-w.

MLA (9th ed.) Citation

SAR, Shilbayeh, et al. "The Polymorphisms of Candidate Pharmacokinetic and Pharmacodynamic Genes and Their Pharmacogenetic Impacts on the Effectiveness of Risperidone Maintenance Therapy Among Saudi Children with Autism." European Journal of Clinical Pharmacology, vol. 80, no. 6, 2024, p. 869, https://doi.org/10.1007/s00228-024-03658-w.